ESAB Corporation delivered a strong third quarter, achieving $728 million in sales, an 8% increase year-over-year. The company returned to positive core organic growth and saw mid-single-digit growth in its Equipment and Automation segment. Net income was $64 million, and diluted EPS was $1.04, with core adjusted EPS reaching $1.32. The completion of the EWM acquisition further strengthened its heavy equipment and automation portfolio.

ESAB Corporation delivered a strong second quarter in 2025, with sales reaching $716 million. The company achieved a record core adjusted EBITDA margin of 20.4% and reported diluted EPS of $1.12, with core adjusted EPS at $1.36. Strategic acquisitions in medical gas control and welding equipment further strengthened its market position, leading to an upward revision of its full-year 2025 guidance.

ESAB Corporation reported first quarter 2025 sales of $678 million, a 2% decrease year-over-year, but flat on a core organic growth basis. Net income was $70 million, and core adjusted diluted EPS was $1.25. Core adjusted EBITDA increased by 4% with margin expansion of 100 basis points.

ESAB Corporation posted Q4 2024 sales of $671 million, reflecting a 3% decline year-over-year. Net income from continuing operations stood at $72 million, with an adjusted EPS of $1.28. The company completed the acquisition of SUMIG to expand its automation portfolio and anticipates modest organic growth in 2025.

ESAB Corporation reported a slight decrease in third quarter sales, but achieved a 1% increase on a core organic growth basis. The company reported net income of $69 million, or $1.13 diluted earnings per share, and core adjusted net income of $77 million, or $1.25 diluted earnings per share. Core adjusted EBITDA rose 6% with margin expansion. The company has updated its full year 2024 outlook with an increased core adjusted EBITDA and EPS.

ESAB Corporation reported second quarter sales of $707 million, a decrease of 2% on a reported basis but an increase of 1% on a core organic growth basis. The company reported net income of $84 million, or $1.37 diluted earnings per share, and core adjusted EBITDA of $134 million, up 6% with margins expanding 150 basis points to 20.1%.

ESAB Corporation reported a strong start to 2024 with record first quarter sales of $690 million, a 1% increase year-over-year, and core organic growth of 2%. Core adjusted EBITDA rose by 9% to $123 million, with margins expanding by 140 basis points to 18.8%. The company completed the acquisition of Sager S. A. and announced an agreement to acquire SUMIG Ltda.

ESAB Corporation reported record fourth quarter sales of $689 million, a 4% increase year-over-year. Net income from continuing operations was $58 million, or $0.96 diluted earnings per share, while core adjusted EBITDA rose 18% to $126 million with margins expanding to 19.4%.

ESAB Corporation reported record third-quarter results, with a 10% increase in sales and a 7% core organic growth. The company's operating income was $101 million, and the core adjusted EBITDA rose by 23% to $118 million. Based on the strong year-to-date performance, ESAB has raised its full-year 2023 outlook.

ESAB Corporation reported record financial results for the second quarter of 2023, with sales up 9% and core organic growth of 6%. Net income from continuing operations attributable to ESAB was $67 million, and core adjusted EBITDA rose 20% to $127 million. The company raised its full-year 2023 outlook due to strong first-half performance and confidence in its long-term strategy.

ESAB Corporation reported a 6% increase in sales, driven by a 7% core organic growth in Q1 2023. The company's net income was $33 million, with core adjusted EBITDA rising by 12% to $113 million. ESAB raised its full-year 2023 outlook, expecting continued growth and profitability.

ESAB Corporation reported a 6% increase in fourth-quarter sales, reaching $664 million, with an 11% core organic growth. The company's GAAP net income was $59 million, with diluted earnings per share at $0.97. Core adjusted EBITDA rose by 10% to $107 million.

ESAB Corporation reported strong Q3 2022 financial results, with a 2% increase in sales and 10% core organic growth. The company's net income was $53 million, or $0.88 diluted per share, and core adjusted EBITDA rose 5% to $96 million. ESAB also completed the acquisition of Ohio Medical to strengthen its gas control business.

ESAB Corporation announced record second quarter sales of $661.2 million, a 5% increase, including 9% organic growth. Adjusted EBITDA rose 6% to $110.5 million, and the company reaffirmed its full year 2022 guidance.

ESAB Corporation reported strong first quarter 2022 results, with record sales of $647.9 million, a 14% increase on a reported basis, and adjusted EPS of $1.17. The company also achieved adjusted EBITDA of $109.3 million, up 16% versus the prior year. ESAB reaffirmed its full year 2022 guidance, excluding Russia for the remainder of the year.